Follow The Filings

BMEA Biomea Fusion Inc.

Health Care, filed as BIOMEA FUSION INC (COM), Equity Among managers we track Quote on Google Finance, opens in a new tab

No current holdings among managers we track for this security. See ownership history or the ownership grid, activity, or search.

Insider trades

Open-market buys and sales by BMEA's executives, directors and 10% owners in the last 12 months, from their Form 4s

All BMEA insider trades
  • $197K bought by 2 insiders
  • None no sales outside a trading plan
  • None no planned (10b5-1) sales
  1. Rainer M Erdtmann See Remarks
    Buy
    $43K 30,000 shares at $1.43 +4.3% to stake
    Traded Dec 11, 2025 Filed Dec 15, 2025
    ↗
  2. Michael J.m. Hitchcock CEO
    Buy
    $99K 100,000 shares at $0.9900 +667% to stake
    Traded Dec 2, 2025 Filed Dec 4, 2025
    ↗
  3. Rainer M Erdtmann See Remarks
    Buy
    $55K 50,000 shares at $1.09 +7.8% to stake
    Traded Nov 28, 2025–Dec 1, 2025 Filed Dec 2, 2025
    ↗

SEC filings

Recent issuer filings from EDGAR, 25 shown.

Filed Form Detail Links
8-K 7.01,8.01,9.01 Filing Doc
424B5 Filing Doc
8-K 8.01 Filing Doc
8-K 9.01 Filing Doc
10-Q Filing Doc
8-K 5.07 Filing Doc
8-K 2.02,9.01 Filing Doc
10-Q Filing Doc
8-K 7.01,8.01,9.01 Filing Doc
DEF 14A Filing Doc
8-K 2.02,9.01 Filing Doc
10-K Filing Doc
8-K 7.01,9.01 Filing Doc
SCHEDULE 13G/A — Filing Doc
SCHEDULE 13G — Filing Doc
SCHEDULE 13G/A — Filing Doc
8-K 7.01,8.01,9.01 Filing Doc
SCHEDULE 13G — Filing Doc
SCHEDULE 13G/A — Filing Doc
SCHEDULE 13G/A — Filing Doc
8-K 2.02,9.01 Filing Doc
10-Q Filing Doc
SCHEDULE 13D/A — Filing Doc
SCHEDULE 13D/A — Filing Doc
424B5 Filing Doc

Source: SEC EDGAR submissions, updated 14 days ago. All on EDGAR

Financials

US-GAAP annual figures by fiscal year, as tagged in Form 10-K. Each value links to its SEC filing.

Income statement

Metric FY2023 FY2024 FY2025
Net income -$117.26M -$138.43M -$61.8M

Balance sheet

Metric FY2023 FY2024 FY2025
Total current assets $179.18M $68.33M $58.05M
Total non-current assets * $20.75M $11.61M $0.522M
Total assets $199.93M $79.94M $58.57M
Total current liabilities $22.86M $21.67M $11.1M
Total non-current liabilities * $7.83M $6.69M $17.92M
Total equity $169.24M $51.57M $29.55M

Cash flow

Metric FY2023 FY2024 FY2025
Cash from operations -$96.59M -$119.89M -$70.37M
Cash from investing -$2.22M -$0.362M —
Cash from financing $163.8M $1.67M $67.9M
Net change in cash $64.99M -$118.59M -$2.47M

Source: SEC companyfacts (US-GAAP 10-K). A * marks a computed figure, not a single XBRL tag. Fiscal years are as the issuer labels them. Follow The Filings does not adjust or audit these figures.

Ownership over time

13Fs that reported it each quarter. Click a bar for that quarter’s holders.